B of A Securities Maintains Buy on Abbott Laboratories, Raises Price Target to $150

Benzinga · 03/10 16:49
B of A Securities analyst Travis Steed maintains Abbott Laboratories (NYSE:ABT) with a Buy and raises the price target from $133 to $150.